EMEA-000183-PIP01-08-M05

  • Email
  • Help

Overview

Product details for Eliquis
Invented nameEliquis
Active substance

Apixaban

Decision numberP/0196/2017
PIP numberEMEA-000183-PIP01-08-M05
Pharmaceutical form(s)Film-coated tablet, Oral liquid
Condition(s)/indication(s)

Prevention of arterial thromboembolism

Prevention of venous thromboembolism

Route(s) of administrationOral use
PIP applicant

Bristol-Myers Squibb / Pfizer EEIG
United Kingdom
Tel. +44 1895523740
E-mail: medical.information@bms.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision